Stockscreener 앱 받기
41.87
0.00%
0.00
전일 마감가:
$41.87
열려 있는:
$41.38
하루 거래량:
1.68M
Relative Volume:
0.90
시가총액:
$3.31B
수익:
-
순이익/손실:
$-119.67M
주가수익비율:
-15.34
EPS:
-2.73
순현금흐름:
$-97.30M
1주 성능:
+2.50%
1개월 성능:
-3.46%
6개월 성능:
+151.32%
1년 성능:
+252.74%
1일 변동 폭
$40.50
$43.16
1주일 범위
$40.50
$45.62
52주 변동 폭
$8.241
$47.65
Mineralys Therapeutics Inc Stock (MLYS) Company Profile
명칭
Mineralys Therapeutics Inc
전화
(888) 378-6240
주소
150 N. RADNOR CHESTER ROAD, RADNOR
MLYS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MLYS
Mineralys Therapeutics Inc
|
41.87 | 3.31B | 0 | -119.67M | -97.30M | -2.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mineralys Therapeutics Inc Stock (MLYS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-11 | 개시 | Jefferies | Hold |
| 2024-07-10 | 개시 | H.C. Wainwright | Buy |
| 2024-04-02 | 개시 | Goldman | Buy |
| 2023-03-07 | 개시 | BofA Securities | Buy |
| 2023-03-07 | 개시 | Credit Suisse | Outperform |
| 2023-03-07 | 개시 | Evercore ISI | Outperform |
| 2023-03-07 | 개시 | Guggenheim | Buy |
| 2023-03-07 | 개시 | Stifel | Buy |
| 2023-03-07 | 개시 | Wells Fargo | Overweight |
모두보기
Mineralys Therapeutics Inc 주식(MLYS)의 최신 뉴스
Catalys Pacific fund sells Mineralys Therapeutics shares for $43.35m By Investing.com - Investing.com Australia
Director’s Major Stock Sale Shakes Up Mineralys Therapeutics! - TipRanks
Catalys Pacific fund sells Mineralys Therapeutics shares for $43.35m - Investing.com
Momentum divergence signals in Mineralys Therapeutics Inc. chartJuly 2025 Institutional & Weekly Stock Performance Updates - newser.com
What moving averages say about Mineralys Therapeutics Inc.Trade Exit Report & Community Consensus Picks - newser.com
How rising interest rates impact Mineralys Therapeutics Inc. stock2025 Risk Factors & Safe Capital Allocation Plans - newser.com
Will Mineralys Therapeutics Inc. stock benefit from commodity pricesNew Guidance & Free Safe Entry Trade Signal Reports - newser.com
Is Mineralys Therapeutics Inc. stock positioned for digital transformationTrade Performance Summary & Safe Swing Trade Setups - newser.com
How Mineralys Therapeutics Inc. stock performs in rate cut cyclesJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
Can Mineralys Therapeutics Inc. hit a new high this monthEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Ranking Mineralys Therapeutics Inc. among high performing stocks via toolsEarnings Miss & Weekly Watchlist of Top Performers - newser.com
Is Mineralys Therapeutics Inc a good long term investmentAnalyst Upgrades & Free Tap Rapid Wealth - earlytimes.in
Mineralys Nears Pivotal FDA Filing as Hypertension Drug Lorundrostat Advances - MyChesCo
(MLYS) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
MLYS Stock Price Dives 11% After Mixed Securities Filing - StocksToTrade
Will Mineralys Therapeutics Inc. stock recover faster than marketJobs Report & High Accuracy Swing Entry Alerts - newser.com
How Mineralys Therapeutics Inc. stock reacts to Fed rate cutsJuly 2025 Selloffs & High Yield Equity Trading Tips - newser.com
Will Mineralys Therapeutics Inc. stock remain a Wall Street favoriteBear Alert & Real-Time Stock Movement Alerts - newser.com
Price action breakdown for Mineralys Therapeutics Inc.Trade Exit Summary & Real-Time Buy Zone Alerts - newser.com
Will Mineralys Therapeutics Inc. stock maintain growth story2025 Year in Review & Fast Gain Swing Trade Alerts - newser.com
Mineralys Therapeutics Inc. (MLYS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Mineralys Therapeutics Shares Fall Following Executives' Stock Sale - MarketScreener
Mineralys Therapeutics’ Stock Dips Amid Earnings Miss - TipRanks
Mineralys Therapeutics director Karydas sells $689k in shares By Investing.com - Investing.com South Africa
Mineralys Therapeutics director Gold sells $1.57m in MLYS stock By Investing.com - Investing.com Nigeria
Has Mineralys Therapeutics Inc. found a price floorJuly 2025 Recap & Capital Efficient Trade Techniques - newser.com
Mineralys therapeutics (MLYS) CFO Adam Levy sells $5.36m in stock By Investing.com - Investing.com South Africa
Mineralys Therapeutics CEO Congleton sells $9 million in stock By Investing.com - Investing.com South Africa
Mineralys therapeutics (MLYS) CFO Adam Levy sells $5.36m in stock - Investing.com Nigeria
Mineralys Therapeutics Insider Sold Shares Worth $5,363,716, According to a Recent SEC Filing - MarketScreener
Insider Sell Alert: CEO Jon Congleton Sells 200,000 Shares of Mi - GuruFocus
Mineralys Therapeutics director Gold sells $1.57m in MLYS stock - Investing.com India
Mineralys Therapeutics director Karydas sells $689k in shares - Investing.com India
Mineralys Therapeutics CEO Congleton sells $9 million in stock - Investing.com India
Multi factor analysis applied to Mineralys Therapeutics Inc.Treasury Yields & Real-Time Stock Entry Alerts - newser.com
Mineralys at Stifel 2025 Healthcare Conference: Strategic Focus on Hypertension - Investing.com
Mineralys Therapeutics Inc (MLYS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):